Details for the presentation include:
Conference | 13th Annual Wells Fargo Securities Healthcare Conference | ||||
Date | Wednesday, September 5, 2018 | ||||
Time | 9:05 a.m. ET | ||||
A live webcast and replay of the presentation (which will be available for at least 30 days following the presentation) can be accessed on the company’s website, www.therapeuticsmd.com, on the Home Page or under the “Investors & Media” section.
About TherapeuticsMD, Inc.
Forward-Looking Statements
This press release by TherapeuticsMD, Inc. may contain forward-looking
statements. Forward-looking statements may include, but are not limited
to, statements relating to TherapeuticsMD’s objectives, plans and
strategies as well as statements, other than historical facts, that
address activities, events or developments that the company intends,
expects, projects, believes or anticipates will or may occur in the
future. These statements are often characterized by terminology such as
“believes,” “hopes,” “may,” “anticipates,” “should,” “intends,” “plans,”
“will,” “expects,” “estimates,” “projects,” “positioned,” “strategy” and
similar expressions and are based on assumptions and assessments made in
light of management’s experience and perception of historical trends,
current conditions, expected future developments and other factors
believed to be appropriate. Forward-looking statements in this press
release are made as of the date of this press release, and the company
undertakes no duty to update or revise any such statements, whether as a
result of new information, future events or otherwise. Forward-looking
statements are not guarantees of future performance and are subject to
risks and uncertainties, many of which are outside of the company’s
control. Important factors that could cause actual results, developments
and business decisions to differ materially from forward-looking
statements are described in the sections titled “Risk Factors” in the
company’s filings with the Securities and Exchange Commission, including
its most recent Annual Report on Form 10-K and Quarterly Reports on Form
10-Q, as well as reports on Form 8-K, and include the following: whether
the
View source version on businesswire.com: https://www.businesswire.com/news/home/20180822005028/en/
Source:
TherapeuticsMD, Inc.
Nichol Ochsner, 561-961-1900, ext. 2088
Vice
President Investor Relations
Nochsner@TherapeuticsMD.com